Improving the Diagnosis and Follow‐Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques
Journal of Clinical Laboratory Analysis · 2025-03 · 39 (5)
DOI: 10.1002/jcla.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 10.02.2025. Verfasst von Noor Al-Huda A Bahar und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Department of Microbiology, University of Anbar, Ramadi, Iraq. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Philadelphia chromosome (Ph) represented a finding of chronic myeloid leukemia (CML) in most cases which formed from t (9; 22) (q34; q11) resulting in the Breakpoint cluster region‐Abelson tyrosine‐protein kinase1 (BCR‐ABL1) fusion gene. Assuming CCE's inaccuracies in diagnosing CML and FISH's limitations with low BCR‐ABL1 percentages, a Predicted‐FISH (Pred‐FISH) was developed. This model predicts treatment response during follow‐up by integrating qRT‐PCR results, White Blood Cell (WBC) counts, and Cytogenetic Response data.
Methods
Quantitative Real‐Time Polymerase Chain Reaction Analysis (qRT‐PCR), fluorescence in situ hybridization (FISH), and Conventional Cytogenetic Examination (CCE or Karyotyping) have been used in the detection and follow‐up of CML patients. The study included 110 individuals, divided into three groups: 31.82% (35 individuals) were newly diagnosed CML patients, another 22.73% (25 individuals) were healthy control samples, and the remaining 45.45% (50 individuals) were previously diagnosed CML patients.
Results
Include BCR‐ABL1 fusion gene levels detected by qRT‐PCR, Ph chromosome presence t (9; 22) (q34; q11) observed by CCE, and WBC counts. The FISH test, used to confirm disease in new patients before treatment, was compared to CCE results due to its insensitivity in certain conditions. Data from CCE, FISH, qRT‐PCR, and WBC for newly diagnosed patients provided a standard for evaluating the Predicted‐FISH.
Conclusion
The FISH technique excels in disease detection with over 98% accuracy and high sensitivity. QRT‐PCR is effective for monitoring CML and BCR‐ABL1 gene levels, indicating MMR and DMR. CCE, while useful for posttreatment monitoring, is less accurate in measuring treatment response over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Department of Microbiology, University of Anbar, Ramadi, Iraq.
- Anbar Health Directorate, Anbar Cancer Center, Ramadi, Iraq.
ORCID-Profile: Noor Al-Huda A Bahar, Mushtak T S Al-Ouqaili, Nabeel M Talib
Zitieren
APA
Bahar, N. A. A., Al-Ouqaili, M. T. S., & Talib, N. M. (2025). Improving the Diagnosis and Follow‐Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques. Journal of Clinical Laboratory Analysis, 39(5). https://doi.org/10.1002/jcla.70001
Vancouver
Bahar NAA, Al-Ouqaili MTS, Talib NM. Improving the Diagnosis and Follow‐Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques. Journal of Clinical Laboratory Analysis. 2025;39(5). doi:10.1002/jcla.70001
BibTeX
@article{Bahar2025,
author = {Bahar, Noor Al-Huda A and Al-Ouqaili, Mushtak T S and Talib, Nabeel M},
title = {Improving the Diagnosis and Follow‐Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
volume = {39},
number = {5},
doi = {10.1002/jcla.70001}
}
EUVIMED